FedEx has expanded its Life Science Center in Gimpo, Korea, enhancing its logistics capabilities to meet the growing demand in the healthcare sector across the Asia Pacific. The new facility, nearly three times larger, features five temperature-controlled areas for pharmaceutical needs and is KGSP-certified. With capacity expansion, FedEx aims to ensure reliable transport of critical healthcare products, supporting the region’s booming pharmaceutical market projected to reach USD 290 billion by 2028. The company leverages its extensive global network and advanced logistics solutions to drive healthcare innovations.